← Evidence map

ReviewAustralian prescriber2025

Lebrikizumab for atopic dermatitis.

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 41164098